Dr. Peter Metrakos is the Greek leader of a research team working on improving survival rates of cancer patients by using breakthrough artificial intelligence (AI) technology. The team of doctors, based in Canada, are working to help patients suffering from colorectal cancer survive an incredibly deadly disease, which as it stands has a five-year survival rate of only 12%. The research team is working with the Research Institute of the McGill University Health Centre (RI-MUHC) to develop personalized medicine in the colorectal cancer field. Current research is based on Metrakos' 2016 research into colorectal cancer cells' relationship to blood vessels. The Greek doctor and his team will use liquid biopsy techniques to separate constituent parts of the cancer patient's blood, in order to understand which are related to the cancer.